[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364279-105":59,"doc-detail-364279-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-of-cytokeratin-19-in-prostatic-adenocarcinoma-a-systematic-review","Expression of cytokeratin 19 in prostatic adenocarcinoma - a systematic review","","Cytokeratins are intracellular proteins used as diagnostic biomarkers or prognostic factors in cancers. Cytokeratin 19 (CK-19) expression has recognized prognostic relevance in some malignancies, yet its role in prostate cancer remains insufficiently clarified. This systematic review evaluates the relationship between CK-19 expression and prostate adenocarcinoma, assessing evidence from eligible studies to determine whether CK-19 associates with disease behavior and patient outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-of-cytokeratin-19-in-prostatic-adenocarcinoma-a-systematic-review/364279/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-of-cytokeratin-19-in-prostatic-adenocarcinoma-a-systematic-review/364279.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the systematic review?","Question",{"text":112,"@type":113},"To examine the relationship between cytokeratin 19 (CK-19) expression and prostate adenocarcinoma, clarifying whether CK-19 correlates with disease progression and prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were eligible studies selected and assessed?",{"text":117,"@type":113},"Studies detecting CK-19 expression in prostate adenocarcinoma were searched in PubMed, Scopus, and Web of Science using prostate cancer and cytokeratin 19 keywords and MeSH terms. Data were extracted and tabulated, following PRISMA guidelines, with quality assessed using the JBI checklist, and the protocol registered in PROSPERO.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the results indicate about CK-19 as a biomarker?",{"text":121,"@type":113},"Across included studies, CK-19 was detected in prostate adenocarcinoma patients and was less common in healthy donors. Higher CK-19 levels were associated with advanced stages and worse prognosis, suggesting diagnostic and prognostic potential.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364279,1790582464,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Shahshenas et al. BMC Cancer (2025) 25:52 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-13456-x](https://doi.org/10.1186/s12885-025-13456-x)  \nSYSTEMATIC REVIEW Open Access  \nExpression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review  \nSina Shahshenas 1, Seyyed Mohammad Hosseini2, Hossein Yarmohammadi3, Masood Soltanipur3* and Mohammadreza Jalali Nadoushan4*  \nAbstract  \nBackground Cytokeratins are intracellular proteins known as diagnostic biomarkers or prognostic factors for certain cancers. Cytokeratin 19 (CK-19) expression has been proven to have prognostic value for some cancers, but its relationship with others, such as prostate cancer (PCa), remains unclear. This systematic review article aimed to examine the relationship between CK-19 expression and prostate adenocarcinoma (PAC) .  \nMethods To include the eligible studies that detected CK-19 expression in PAC, published articles since June 2024 were found using PubMed, Scopus, and Web of Science databases. The “prostate cancer” and “cytokeratin 19”keywords and their Mesh term were used for search databases. Data from the included articles were extracted and tabulated. This study was performed using the PRISMA guidelines, and the JBI checklist was used for the quality assessment. The study protocol was registered in PROSPERO under the“CRD42023472637”code.  \nResults Twenty-one studies were included. Eleven studies used reverse transcription polymerase chain reaction (RT-PCR) to investigate CK-19 expression, four used immunohistochemistry (IHC) staining, three used both  \none-step nucleic acid amplification (OSNA) and hematoxylin and eosin (H&E) methods, and three used the electrochemiluminescence (ECL) technique. CK-19 expression was detected in 301 patients among 619 patients. Additionally, only five out of 80 healthy donors were positive for CK-19 expression.  \nConclusion Available evidence indicates a correlation between CK-19 expression and PAC progression, with higher CK-19 levels associated with advanced stages and worse prognosis. The overall evidence suggests that CK-19 could serve as a diagnostic and prognostic marker in PAC.  \nKeywords Cytokeratin 19, CK-19 expression, Prostatic adenocarcinoma (PAC), Prostate cancer (PCa), Gleason scoresand grades  \n*Correspondence:  \nMasood Soltanipur [masood. noavaran@gmail.com](masood. noavaran@gmail.com)[ ](masood. noavaran@gmail.com)Mohammadreza Jalali Nadoushan [jalalinadooshan@yahoo.com](jalalinadooshan@yahoo.com)  \n1Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran  \n2Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Science (TUMS), Tehran, Iran 3Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran  \n4Department of Pathology, Faculty of Medicine, Shahed University, Tehran, Iran  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nShahshenas et al. BMC Ca","cbCaipivra9xttgn","https://ap.wps.com/l/cbCaipivra9xttgn","pdf",1701130,13,"English","# Abstract\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main objective of the systematic review?\",\"answer\":\"To examine the relationship between cytokeratin 19 (CK-19) expression and prostate adenocarcinoma, clarifying whether CK-19 correlates with disease progression and prognosis.\"},{\"question\":\"How were eligible studies selected and assessed?\",\"answer\":\"Studies detecting CK-19 expression in prostate adenocarcinoma were searched in PubMed, Scopus, and Web of Science using prostate cancer and cytokeratin 19 keywords and MeSH terms. Data were extracted and tabulated, following PRISMA guidelines, with quality assessed using the JBI checklist, and the protocol registered in PROSPERO.\"},{\"question\":\"What do the results indicate about CK-19 as a biomarker?\",\"answer\":\"Across included studies, CK-19 was detected in prostate adenocarcinoma patients and was less common in healthy donors. Higher CK-19 levels were associated with advanced stages and worse prognosis, suggesting diagnostic and prognostic potential.\"}]","Expression of cytokeratin 19 in prostatic adenocarcinoma - a systematic review | PDF",1790156691,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/620464faab4b2a536e6c0293dab86aac.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5811b8b3fb3e9951b1e09c7265558f39.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbf0ca090feeca3efd2ec085c7e72a34.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32a15ffa44040f79c92332763462191c.webp",980,1306]